The Swiss biopharmaceutical company said it undertook both deals to develop new therapeutic and diagnostic applications based around exosomes.
Seven Bridges will add Spatial Transcriptomics' histology and gene expression visualization tool to its platform by the end of the year.
The proceeds from the seed round will enable the company to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.
Investors in Theranos may lose out and some are filing lawsuits, the Wall Street Journal reports.
UgenTec will use the funds to develop new features for its FastFinder software that will be released next year, as well to expand its sales efforts.
ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.
The genomic data startup company said it will use the funds to market and sell its clinical software products around the world.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
The startup, which was founded in 2015 by former BGI employees, is developing next-generation sequencing tests for cancer applications.
William Bains at the Trade Secrets blog examines the behavior of biotech investors in different parts of the world.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.